Safety and Efficacy Study of QR-333 in Patient's With Symptomatic Diabetic Neuropathy - Related Studies

Safety and Efficacy Study of QR-333 in Patient's With Symptomatic Diabetic Neuropathy

This study is ongoing, but not recruiting participants.

Study NCT00568035. Last updated on August 5, 2008. Information provided by Quigley Pharma, Inc.

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		Diabetic Neuropathy

2	Additional conditions recognized in this trial
		Diabetic Neuropathies

3	More general conditions related to this trial
		Diabetes Complications
		Diabetes Mellitus
		Endocrine System Diseases
		Nervous System Diseases
		Neuromuscular Diseases
		Peripheral Nervous System Diseases

4	Interventions listed in this trial
		QR-333

5	Sponsors listed in this trial
		Quigley Pharma, Inc.